Lexicon Pharmaceuticals (LXRX) Cash from Investing Activities Growth (3y) (2013 - 2026)
Lexicon Pharmaceuticals (LXRX) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Lexicon Pharmaceuticals |
750.45 Mn |
579.79 Mn |
20.99 Mn |
-98.41% |
| Date | Value |
|---|
| Mar 31, 2026 |
-98.41% |
| Dec 31, 2025 |
-41.54% |
| Sep 30, 2025 |
38.82% |
| Jun 30, 2025 |
46.35% |
| Mar 31, 2025 |
123.78% |
| Dec 31, 2024 |
106.53% |
| Sep 30, 2024 |
413.84% |
| Jun 30, 2024 |
-42.14% |
| Mar 31, 2024 |
-83.90% |
| Dec 31, 2023 |
5.58% |
| Sep 30, 2023 |
-29.71% |
| Jun 30, 2023 |
-43.51% |
| Mar 31, 2023 |
-34.37% |
| Dec 31, 2022 |
30.47% |
| Sep 30, 2022 |
-35.14% |
| Jun 30, 2022 |
-22.36% |
| Mar 31, 2022 |
17.06% |
| Dec 31, 2021 |
-53.01% |
| Sep 30, 2021 |
-26.14% |
| Jun 30, 2021 |
-33.17% |
